Zomig Rapimelt Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Zomig Rapimelt is well tolerated. Adverse reactions are typically mild/moderate, transient, not serious and resolve spontaneously without additional treatment.
Possible adverse reactions tend to occur within 4 hours of dosing and are no more frequent following repeated dosing.
The incidences of ADRs associated with Zomig therapy are tabulated as follows according to the format recommended by the Council for International Organizations of Medical Sciences (CIOMS III Working Group; 1995). (See table.)

Click on icon to see table/diagram/image

View ADR Monitoring Form

Zomig Rapimelt Adverse Reactions

zolmitriptan

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma